Published in Int J Immunopathol Pharmacol on June 12, 2008
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med (1998) 8.56
Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med (1999) 5.65
Metformin in non-alcoholic steatohepatitis. Lancet (2001) 3.63
Determinants of adherence to osteoporosis treatment in clinical practice. Osteoporos Int (2006) 2.79
Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet (1997) 2.78
Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology (2001) 2.74
Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol (1998) 2.70
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Mass in Rheumatoid Arthritis. J Rheumatol (2000) 2.47
Long-lasting sport practice and lone atrial fibrillation. Eur Heart J (2002) 2.26
Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology (1997) 2.21
Noninvasive mechanical ventilation in the weaning of patients with respiratory failure due to chronic obstructive pulmonary disease. A randomized, controlled trial. Ann Intern Med (1998) 2.16
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J Clin Invest (2001) 2.10
Uncoupling of inflammatory chemokine receptors by IL-10: generation of functional decoys. Nat Immunol (2000) 2.01
Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol (1994) 2.01
R990G polymorphism of calcium-sensing receptor does produce a gain-of-function and predispose to primary hypercalciuria. Kidney Int (2007) 2.01
Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am J Med (1996) 1.99
Hypertension-associated point mutations in the adducin alpha and beta subunits affect actin cytoskeleton and ion transport. J Clin Invest (1996) 1.83
Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men. J Clin Endocrinol Metab (2013) 1.77
Strontium absorption and excretion in normocalciuric subjects: relation to calcium metabolism. Clin Chem (1998) 1.76
Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant (2007) 1.69
Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int (2001) 1.58
Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer (1996) 1.57
Study of the mass and spin-parity of the Higgs boson candidate via its decays to Z boson pairs. Phys Rev Lett (2013) 1.56
Indwelling ureteral stents and sexual health: a prospective, multivariate analysis. J Urol (2007) 1.55
Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol (2001) 1.55
Autoimmune hemolytic anemia and human immunodeficiency virus (HIV) infection. Ann Intern Med (1988) 1.54
Protective role of tauroursodeoxycholate during harvesting and cold storage of human liver: a pilot study in transplant recipients. Transplantation (2001) 1.53
Elective segmental ureterectomy for transitional cell carcinoma of the ureter: long-term follow-up in a series of 73 patients. BJU Int (2012) 1.51
Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48
Treatment of an aneurysm of the coeliac axis by transluminal steel wire occlusion. Eur J Vasc Endovasc Surg (1997) 1.48
Blood pressure changes produced by kidney cross-transplantation between spontaneously hypertensive rats and normotensive rats. Clin Sci Mol Med (1974) 1.47
CSF T-cell subsets in multiple sclerosis: relationship to cerebrospinal fluid myelin basic protein and clinical activity. J Neurol (1989) 1.46
Noninvasive management of obstructing ureteral stones using electromagnetic extracorporeal shock wave lithotripsy. Surg Endosc (2008) 1.46
Physiological carotid body denervation during aging. Adv Exp Med Biol (2009) 1.45
The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood (1998) 1.42
Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. Hum Mol Genet (2000) 1.34
Towards a diagnostic and therapeutic consensus in male osteoporosis. Osteoporos Int (2011) 1.33
Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens (2001) 1.30
Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniques. Hum Reprod (2004) 1.29
Left ventricular mass, stroke volume, and ouabain-like factor in essential hypertension. Hypertension (1999) 1.28
Management of superficial vein thrombosis and thrombophlebitis: status and expert opinion document. Angiology (2007) 1.28
Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol Sci (2001) 1.26
Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int (2008) 1.26
Measurement of the electron charge asymmetry in inclusive W production in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 1.23
Tumor seeding in urological laparoscopy: an international survey. J Urol (2004) 1.21
Search for new physics in the multijet and missing transverse momentum final state in proton-proton collisions at √s = 7 TeV. Phys Rev Lett (2012) 1.19
Azimuthal anisotropy of charged particles at high transverse momenta in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2012) 1.19
Accurate prediction of autologous stem cell apheresis yields using a double variable-dependent method assures systematic efficiency control of continuous flow collection procedures. Vox Sang (2006) 1.19
Bone fragility in men--where are we? Osteoporos Int (2006) 1.19
Antibodies of the anti-Yo and anti-Ri type in the absence of paraneoplastic neurological syndromes: a long-term survey of ovarian cancer patients. J Neurol (1997) 1.18
Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut. Gastroenterology (1983) 1.16
The natural history of clinical operational tolerance after kidney transplantation through twenty-seven cases. Am J Transplant (2012) 1.15
Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites. J Pharmacol Exp Ther (1986) 1.15
A knotted multi-length ureteral stent: a rare complication. Urol Res (2004) 1.13
Electrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumors. Med Biol Eng Comput (2012) 1.11
Hypertension may be transplanted with the kidney in humans: a long-term historical prospective follow-up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J Am Soc Nephrol (1996) 1.11
Search for a W' or techni-ρ decaying into WZ in pp Collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2012) 1.10
Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension (1997) 1.10
Search for new physics with same-sign isolated dilepton events with jets and missing transverse energy. Phys Rev Lett (2012) 1.09
Evidence for an interaction between adducin and Na(+)-K(+)-ATPase: relation to genetic hypertension. Am J Physiol (1999) 1.08
Isozyme-dependent sensitivity of adenylyl cyclases to P-site-mediated inhibition by adenine nucleosides and nucleoside 3'-polyphosphates. J Biol Chem (1997) 1.07
Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages. Clin Dev Immunol (2011) 1.07
Prognostic indicators in compensated cirrhosis. Am J Gastroenterol (1991) 1.06
Apraxia in deep cerebral lesions. J Neurol Neurosurg Psychiatry (1983) 1.06
Galactose elimination capacity and liver volume in aging man. Hepatology (1988) 1.06
IL-2-regulated expression of the monocyte chemotactic protein-1 receptor (CCR2) in human NK cells: characterization of a predominant 3.4-kilobase transcript containing CCR2B and CCR2A sequences. J Immunol (1997) 1.05
Measurement of the Υ1S, Υ2S, and Υ3S polarizations in pp collisions at sqrt[s] = 7 TeV. Phys Rev Lett (2013) 1.05
The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology (1996) 1.04
Diagnosis of Pneumocystis carinii pneumonia in AIDS patients by using polymerase chain reactions on serum specimens. J Infect Dis (1995) 1.04
Alpha-adducin polymorphisms and renal sodium handling in essential hypertensive patients. Kidney Int (1998) 1.04
Microdeletions in interval 6 of the Y chromosome detected by STS-PCR in 6 of 33 patients with idiopathic oligo- or azoospermia. Cytogenet Cell Genet (1996) 1.03
Kaposi's sarcoma and AIDS: frequency of gastrointestinal involvement and its effect on survival. A prospective study in a heterogeneous population. Scand J Gastroenterol (1991) 1.03
Pathological fractures in AIDS patients with osteopenia and osteoporosis induced by antiretroviral therapy. AIDS (2001) 1.03
Role of metalloproteases in the release of the IL-1 type II decoy receptor. J Biol Chem (1997) 1.02
Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. J Hepatol (1995) 1.02
Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton. J Urol (1985) 1.02
Etomidate and corticotrophic axis. Arch Int Pharmacodyn Ther (1982) 1.01
Plasma ouabain-like factor during acute and chronic changes in sodium balance in essential hypertension. Hypertension (2001) 1.01
CA-Repeat polymorphism in intron 1 of HSD11B2 : effects on gene expression and salt sensitivity. Hypertension (2000) 1.01
Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues. Ann Neurol (1987) 1.01
The Italian version of the Functional Disability Index of the Health Assessment Questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol (1993) 1.00
Age-dependent glomerulosclerosis and proteinuria occurring in rats of the Milan normotensive strain and not in rats of the Milan hypertensive strain. Lab Invest (1986) 1.00
PST2238: a new antihypertensive compound that antagonizes the long-term pressor effect of ouabain. J Pharmacol Exp Ther (1998) 1.00
Cementless hip arthroplasty with a modular neck. Chir Organi Mov (2002) 0.99
Ablation of bone cells by electroporation. J Bone Joint Surg Br (2010) 0.99
Adhesion, transendothelial migration, and reverse transmigration of in vitro cultured dendritic cells. Blood (1998) 0.99
IL-15 is chemotactic for natural killer cells and stimulates their adhesion to vascular endothelium. J Leukoc Biol (1997) 0.99
Quality of life and body image in the assessment of psychological impact of lipodystrophy: validation of the Italian version of assessment of body change and distress questionnaire. Qual Life Res (2006) 0.99
Alpha-adducin polymorphism in hypertensives of South African ancestry. Am J Hypertens (2000) 0.98
Intracavernous prostaglandin E1 infusion in diabetes with associated ischemic necrosis of the glans penis. J Urol (2004) 0.98
Bone marrow stromal damage after chemo/radiotherapy: occurrence, consequences and possibilities of treatment. Leuk Lymphoma (2001) 0.98
Interleukin-12 is chemotactic for natural killer cells and stimulates their interaction with vascular endothelium. Blood (1994) 0.98
Endogenous ouabain and cardiomyopathy in dialysis patients. J Intern Med (2007) 0.97
Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo. Gene Ther (2000) 0.97
Cutaneous fibrinolytic activity in primary hypertrophic osteoarthropathy. Scand J Rheumatol (1987) 0.97
Predictors of health-related quality of life in patients with chronic liver disease. Aliment Pharmacol Ther (2009) 0.97
Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology (1982) 0.97